Background-Hypertension, a strong determinant of cardiovascular disease risk, has been documented among elite, professional American-style football (ASF) players. The risk of increased blood pressure (BP) and early adulthood hypertension among the substantially larger population of collegiate ASF athletes is not known. Methods and Results-We conducted a prospective, longitudinal study to examine BP, the incidence of hypertension, and left ventricular remodeling among collegiate ASF athletes. Resting BP and left ventricular structure were assessed before and after a single season of competitive ASF participation in 6 consecutive groups of first-year university athletes (n=113). ASF participation was associated with significant increases in systolic BP (116±8 versus 125±13 mm Hg; P<0.001) and diastolic BP (64±8 mm Hg versus 66±10 mm Hg; P<0.001). At the postseason assessment, the majority of athletes met criteria for Joint National Commission (seventh report) prehypertension (53 of 113, 47%) or stage 1 hypertension (16 of 113, 14%). Among measured characteristics, lineman field position, intraseason weight gain, and family history of hypertension were the strongest independent predictors of postseason BP. Among linemen, there was a significant increase in the prevalence of concentric left ventricular hypertrophy (2 of 64 [3%] versus 20 of 64 [31%]; P<0.001) and change in left ventricular mass correlated with intraseason change in systolic BP (R=0.46, P<0.001). Conclusions-Collegiate ASF athletes may be at risk for clinically relevant increases in BP and the development of hypertension. Enhanced surveillance and carefully selected interventions may represent important opportunities to improve later-life cardiovascular health outcomes in this population. (Circulation. 2013;128:524-531.)
H ypertension affects 30% of the adult population in the United States 1,2 and is a major risk factor for cardiovascular disease. 3 Starting at 115/75 mm Hg, each 20-mm Hg increase in systolic blood pressure (SBP) and 10-mm Hg increase in diastolic blood pressure (DBP) doubles the risk of cardiovascular disease and mortality. 4 Importantly, emerging data indicate that blood pressure (BP) in early adulthood is associated with cardiovascular disease risk in later life. 5 Identification of populations at risk for early adult hypertension is therefore of paramount importance.
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Previous cross-sectional studies document a high prevalence of hypertension, 6 concentric left ventricular (LV) hypertrophy, 7 and premature cardiovascular mortality 8 among professional American-style football (ASF) players. To what degree these findings apply to the >1 million younger men who participate in competitive high school or collegiate ASF in the United States annually 9,10 is not known. The association between ASF participation, BP, and cardiac remodeling in young, otherwise healthy athletes has not been well characterized.
We therefore designed the present prospective, longitudinal study to examine the hypothesis that collegiate ASF participation leads to clinically and statistically significant increases in resting BP. Furthermore, we hypothesized that intraseason increases in resting BP are a key determinant of the concentric LV remodeling that has been documented in this population.
Methods
We conducted a prospective, longitudinal, observational study to examine BP trends, LV remodeling, and the incidence of hypertension among competitive ASF participants. From 2006 through 2011, we enrolled newly matriculated varsity-level ASF athletes and a control group of age-and sex-matched endurance-trained athletes who participated in The Harvard Athlete Initiative, an ongoing research program designed to address numerous issues relevant to athlete health and exercise physiology. Specifically, anthropometric data, resting BP, and LV structural parameters were assessed before and after a single season of competitive ASF participation in the 6 consecutive groups of first-year university ASF athletes. The institutional review boards of Partners
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Healthcare and Harvard University approved the protocol before study initiation. Each participant provided written consent at enrollment.
Study Population
ASF athletes were eligible to participate if they were ≥18 years of age and recruited members of the official Harvard University ASF team. The following clinical data were obtained on all subjects at the time of enrollment: age (years), height (inches), weight (pounds), current and past medication use, and personal and family history of hypertension. 11 Body surface area was calculated with the Mosteller 12 formula. Each participant underwent BP measurements and transthoracic echocardiography at the time of study enrollment (preseason) and at the end of the ASF season (postseason) as detailed below. Exercise training volume during the prestudy period, defined as the 8 weeks before baseline assessment, was collected. Training volumes during the prestudy period were characterized by total number of hours per week dedicated to either endurance or strength activities. Endurance activity was defined as running, cycling, swimming, rowing, or using an aerobic machine at an effort sustainable for ≥20 minutes. Strength activity was defined as weight lifting, plyometric exercise, and sprint running drills. The study period began at the time of enrollment and lasted for the course of the ASF season (90 days). Field position for each ASF participant was classified as either lineman or nonlineman as previously proposed. 13 Specifically, linemen included players at the tackle, guard, center, or defensive end positions; nonlinemen included quarterbacks, running backs, wide receivers, tight ends, linebackers, cornerbacks, safeties, kickers, and punters. Daily data were recorded on the duration and type of training activities performed during the ASF season. Each participant was subject to testing for performance-enhancing drugs as dictated by National Collegiate Athletic Association standards. Subjects were excluded from the final data analysis if they undertook any breaks in training of ≥3 days during the ASF season because of injury or any other circumstances.
Control Population
To determine whether observed changes in BP among the study population were specific to ASF participation, a control population of competitive athletes participating in an alternative sport was enrolled and studied in an identical fashion. Specifically, newly matriculated members of the varsity men's rowing team were enrolled from 2006 to 2011. These athletes were chosen because they completed a similar amount of exercise over the study period 14 and perform primarily isotonic/endurance-based training as previously reported. 15, 16 For the present study, the final control population was confined to rowers who were age matched to athletes in the ASF study population. Demographic and exercise training data were recorded as detailed above. BP measurements, as detailed below, were made before and after 90 days of team-based endurance exercise training, which included preparation for and participation in competitive events, and paralleled the study period of the ASF season.
BP Measurement
BP was measured at study enrollment (preseason) and at the postseason assessment with a mercury column sphygmomanometer and an appropriately sized cuff. BP was measured while participants were in the supine position after at least 10 minutes of quiet rest. Reported values represent the average of triplicate measurements. BP was classified according to the most recent Joint National Commission (JNC-7) guidelines into the following categories: normal (SBP <120 mm Hg and DBP <80 mm Hg), prehypertensive (SBP=120 to 139 mm Hg or DBP=80 to 89 mm Hg), and stage 1 or greater hypertension (SBP ≥140 mm Hg or DBP ≥90 mm Hg). 3
Echocardiography Protocol
Transthoracic echocardiography was performed with a commercially available echocardiography system (Vivid-I, GE Healthcare, Milwaukee, WI) with a 1.9-to 3.8-MHz phased-array transducer. Echocardiography was performed by a sonographer credentialed in cardiac ultrasound or a cardiologist trained in echocardiography. Transthoracic echocardiography was performed at the university health service building or the university athletic training facility. Participants were imaged at rest ≥12 hours after the most recent exercise training session. Two-dimensional imaging was performed from standard parasternal and apical transducer positions with frame rates of 60 to 100 frames per second. All data were stored digitally, and offline data analysis was performed (EchoPac, version 7, GE Healthcare) by 2 cardiologists (R.B.W., A.L.B.) blinded to study time point. Cardiac structural measurements were made in accord with current guidelines. 17 LV volume was determined with the modified Simpson biplane technique. LV mass was calculated using the arealength method, which was chosen on the basis of previous accuracy validation and because it accounts for LV morphology in both the short-and long-axis dimensions. 17 LV hypertrophy was defined as LV mass index >115 g/m 2 . Relative wall thickness was calculated as follows: [interventricular septal thickness (mm)+posterior wall thickness (mm)]/LV end-diastolic diameter (mm). Concentric LV hypertrophy was defined by a relative wall thickness >0.42 with an LV mass index >115 g/m 2 ; eccentric LV hypertrophy was defined by a relative wall thickness ≤0.42 and an LV mass index >115 g/m 2 . 17 Resting heart rates were obtained from the final image of each echocardiographic study.
Statistical Analysis
The Shapiro-Wilk test was used to determine the normality of distribution. Categorical variables are presented as proportions; continuous variables are presented as mean±SD. Categorical variables were compared by use of the Fisher exact test. Continuous variables were assessed with the Student paired t test (or 1-way ANOVA if comparisons involved >2 groups with post hoc t testing) for normally distributed variables or the Mann Whitney U test for nonnormally distributed variables. Linear regression analysis was used to identify factors associated with postseason SBP. Factors with a value of P<0.10 were included in a forward stepwise multivariate linear regression analysis to identify factors independently associated with postseason SBP. To determine predictors of JNC-7 stage 1 or greater hypertension at postseason, an outcome of clinical significance, univariate and multivariate logistic regression analyses were performed. Factors with a univariate value of P<0.10 were tested in a forward stepwise multivariate logistic regression analysis to identify independent predictors of JNC-7 stage 1 hypertension (SBP ≥140 mm Hg) at postseason. Analyses were performed with Stata software (version 8, StataCorp). A value of P<0.05 was considered significant.
Results

Study Population
Of 132 ASF participants enrolled over 6 consecutive seasons, 113 completed the index ASF season without a break in participation and are included in this analysis. This all-male cohort (age=19±1 years) comprised 64 linemen (height=186±6 cm; body mass=100±15 kg) and 49 nonlinemen (height=188±7 cm; body mass=93±11 kg) with the following ethnic distribution: white, 62%; black, 27%; Asian, 8%; Hispanic/Latino, 1%; and other, 2%. Prescription medication use (n=16 participants) included methylphenidate (n=6), inhaled bronchodilators or corticosteroids (n=4), and topical antibiotics (n=6). One individual had a previously established diagnosis of hypertension, and 30 of 113 (27%) had a family history of hypertension. Participants performed 7.8±2.7 h/wk of exercise during the 8 weeks before enrollment that consisted of both endurance (3.7±1.8 h/wk) and strength (4.6±2.9 h/wk) activities. The ASF season was made up of organized team practices and supervised fitness sessions on 6 of 7 days per week, which amounted to 17.4±1.1 h/wk over a 90-day period. The majority of exercise training during the study period comprised strength-based activity (15.8±1.0 h/wk). 
Control Population
Seventy male university rowers (age=19±1 years; height=189±6 cm) completed a 90-day endurance-based training program without a break in participation. Prescription medication use (n=11) was similar to that of the study population and was limited to either methylphenidate or topical antibiotics. A family history of hypertension was present in 11 of 70 rowers (16%). Control participants performed 7.6±2.8 h/ wk of exercise during the 8 weeks before enrollment (endurance training=6.2±1.5 h/wk; strength training=1.4±1.9 h/wk), followed by 14.4±2.1 h/wk of exercise during the 90-day study period (endurance training=12.9±0.9 h/wk; strength training=1.6±1.4 h/wk). Body mass increased over the course of the study period (preseason=87.8±7.3 kg versus postsea-son=88.3±6.6 kg; P<0.001).
BP Before and After ASF Participation
At the preseason assessment, the majority of ASF participants (69 of 113, 61%) had normal SBP and DBP, whereas the remaining 44 of 113 (39%) were prehypertensive. No individuals met criteria for JNC-7 stage 1 hypertension at preseason. Group mean SBP and DBP at preseason and postseason for each study year are shown in Figure 1 . There were statistically significant increases in SBP in each study year, whereas DBP increased significantly in 4 of 6 years. In a pooled analysis of all participants (n=113), SBP increased by 9±7 mm Hg (preseason=116±8 mm Hg versus postsea-son=125±13 mm Hg; P<0.001) and DBP increased by 2±8 mm Hg (preseason=64±8 mm Hg versus postseason=66±10 mm Hg; P<0.001). At postseason, the majority of participants met the criteria for either prehypertension (53 of 113, 47%) or JNC-7 stage 1 hypertension (16 of 113, 14%), whereas only 44 of 113 (39%) maintained normal SBP and DBP (Table 1) . Athletes in the control group experienced a nonsignificant reduction in SBP (preseason=114±9 mm Hg versus postsea-son=112±10 mm Hg; P=0.06) and a small but statistically significant decrease in DBP (preseason=60±9 mm Hg versus postseason=59±8 mm Hg; P=0.005) after 90 days of endurance training (Table 1) . To examine the potential association between weight change and BP in the control group, we dichotomized the control group across the median weight gain value (median value=0.45 kg; top 50%=1.9±1.2 kg versus bottom 50%=−0.9±0.9 kg; P<0.001) but found no difference in either ΔSBP (Δtop 50%=−1±−9 mm Hg versus Δbottom 50%=−3±6 mm Hg; P=0. 19) or ΔDBP (Δtop 50%=−2±4 mm Hg versus Δbottom 50%=−2±6 mm Hg; P=0.98). Importantly, no rowers met criteria for JNC-7 stage 1 hypertension before or after the study period.
Influence of ASF Field Position on BP
Comparative statistics for linemen and nonlinemen are shown in Table 2 . Linemen had significantly higher SBP and DBP at preseason and were more likely to meet criteria for prehypertension (33 of 64 [52%] versus 11 of 49 [22%]; P=0.002) than nonlinemen. Linemen demonstrated significantly greater increases in body mass (3±4 versus 0±2 kg; P<0.001), SBP (12±9 versus 4±7 mm Hg; P<0.001), and DBP (4±8 versus −1±7; P<0.001) during the ASF season. It is noteworthy that among the linemen who maintained or lost body mass during the season (n=16, 25%), there was still a highly significant increase in SBP (8±4 mm Hg; P<0.001). At postseason, 53 of 64 linemen (83%) either were prehypertensive (37 of 64, 58%) or met criteria for JNC-7 stage 1 hypertension (16 of 64, 25%). In contrast, the majority of nonlinemen maintained normal SBP and DBP, and none demonstrated JNC-7 stage 1 hypertension ( Figure 2 ).
LV Remodeling in ASF Athletes
Echocardiographic LV parameters are shown in Table 3 . LV hypertrophy was present in 15 of 113 participants (13%) at the preseason assessment and was similarly prevalent between linemen (10 of 64, 16%) and nonlinemen (5 of 49, 10%; P=0.58). There was no significant correlation between either SBP or DBP and LV mass at preseason. LV mass increased significantly over the course of the ASF season in the entire cohort (100±12 versus 108±14 g/m 2 ; P<0.001), and the magnitude of increase was similar between position groups (linemen Δ=9.9±8.5 versus nonlinemen Δ=7.9±8.9 g/m 2 ; P=0.23). At postseason, the overall prevalence of LV hypertrophy increased to 32% and was similar among linemen (24 of 64, 38%) and nonlinemen (12 of 49, 24%; P=0. 16 ). However, the geometric patterns of LV hypertrophy differed by field position. Concentric LV hypertrophy was the dominant pattern among linemen (20 of 24, 83%) but was present in only a single nonlineman (1 of 12, 8%; P<0.001). Among linemen, intraseason changes in LV mass and absolute postseason LV mass were significantly associated with changes in SBP and postseason SBP, respectively (Figure 3 ). 
Factors Associated With SBP
Univariate linear regression analyses for factors significantly associated with postseason SBP are shown in Table 4 . In a multivariate linear regression model controlling for preseason hypertension and intraseason weight gain, a family history of hypertension and lineman field position were independent predictors of postseason SBP (Table 4 ). Univariate logistic regression analysis for factors associated with JNC-7 stage 1 or greater hypertension at postseason is shown in Table 5 . In a multivariate logistic regression model, excluding field position because of its status as a perfect predictor, weight gain and family history of hypertension were strong independent predictors of postseason hypertension (Table 5) . A nonsignificant difference toward black ethnicity predicting postseason hypertension was also observed in the multivariate logistic regression model (odds ratio=4.6; 95% confidence inter-val=0.98-22.01; P=0.054).
Discussion
Clinically relevant increases in BP were observed in collegiate ASF athletes after participation in a single competitive season. Among collegiate ASF players without hypertension at preseason, ≈15% were overtly hypertensive as defined by JNC-7 criteria by postseason. Several readily available clinical factors, including lineman field position, intraseason weight gain, and a family history of hypertension, identify ASF athletes at greatest risk. In addition, our analyses suggest that the concentric LV hypertrophy in this population is caused in part by increases in resting BP, not simply by the transient isometric stress that occurs during training and competition.
Hypertension is a well-established risk factor for the development of atherosclerotic cardiovascular disease and LV dysfunction. 18, 19 Several prior studies have documented that BP elevation during adolescence and young adulthood confers an increased risk of cardiovascular mortality later in life, 20,21 even after adjustment for middle-aged hypertension. 5 Therefore, recognition of populations at increased risk for early-life hypertension provides important opportunities to reduce subsequent cardiovascular morbidity and mortality. Novel results from the present study demonstrate that ASF football participants may be one such population.
Previous work has established an association between ASF participation, hypertension, 6 and increased cardiovascular mortality. 8 In 1994, the National Institute for Occupational Safety and Health conducted a mortality study to investigate the rate and causes of death among prior National Football League players. This study examined health outcomes among 6848 retired players and found that although professional football players had an overall 46% lower overall mortality rate than the general US male population, those who played a lineman position had a 50% greater risk of cardiovascular disease than the general population. 8 It is noteworthy that deaths among linemen were attributable almost exclusively to hypertensive and ischemic heart disease, and subsequent work has documented a higher prevalence of hypertension in retired National Football League players compared with an age-matched population. 6 The present study advances our understanding of the relationship between ASF participation and later-life adverse cardiovascular outcomes in several ways. First, we examined first-year collegiate ASF athletes who have relatively little cumulative prior ASF exposure. In doing so, we show that the attributes presumably responsible for increased cardiovascular mortality in the retired professionals, specifically hypertension and LV hypertrophy, begin to develop at a relatively early point in the ASF athlete's career. Second, the use of a longitudinal, repeated-measures design affords an opportunity to establish temporal relationships between the exposure, ASF participation, and key continuous and categorical outcome variables of SBP and hypertension, respectively. The study design was strengthened by the use of an endurance-trained control group. Comparison of strength-trained ASF athletes with endurance-trained rowing athletes indicates that the BP increase and the development of hypertension are not a uniform response to all forms of vigorous exercise training. Third, our findings expand on prior work documenting important cardiovascular differences between lineman and nonlineman ASF field positions. 13 Specifically, we demonstrate that increases in BP and the risks of developing both overt hypertension and concentric LV hypertrophy are highest among those who participate at the lineman position.
There are important clinical implications of our findings. Practitioners should be aware that ASF participants may be a youthful population at increased risk for developing hypertension. Our analyses demonstrate that ASF athletes at the highest risk of developing hypertension can be identified by easily assessed characteristics, including field position, intraseason weight gain, and family history of hypertension. Hypertensive ASF athletes will likely benefit from increased surveillance, specifically measurements of resting BP before, during, and after competitive ASF participation, coupled with directed measures to treat hypertension, including dietary, 22, 23 lifestyle, 24 and pharmacological interventions as recommended by current guidelines. 25 Potential treatment strategies should be carefully selected to preserve athletic performance and to simultaneously normalize BP. Future study is required to determine whether such interventions will translate into reduced cardiovascular morbidity and mortality. Additionally, is an important question requiring future investigation. Findings from the study also have important implications with respect to our current understanding of the athlete's heart. As first proposed by Morganroth et al 26 in 1975 and confirmed in subsequent studies, 14 athletes who participate in isotonic/ endurance training tend to develop eccentric LV hypertrophy, whereas athletes exposed to isometric/strength training are more likely to develop the concentric variant. It is conventionally assumed that LV remodeling in athletes is caused by the transient but repetitive hemodynamic perturbations that occur during the hours of actual athletic activity. In the present study, linemen who perform predominantly isometric training developed concentric LV hypertrophy. Although this observation supports the Morganroth et al hypothesis, it does so with a novel, potentially critical mechanistic insight. Our data suggest that the development of persistent resting hypertension during an exercise training period, not simply the repetitive bursts of BP increase with isometric activity, underlies the development of concentric LV hypertrophy. This may explain the results of a recent longitudinal study in which individuals who maintained normal BP failed to develop LV hypertrophy during a 6-month period of strength training. 27 Our findings suggest that the concentric LV hypertrophy among strength athletes, traditionally presumed to be a benign adaptation, is actually a mild, previously unrecognized form of hypertensive LV remodeling that may carry adverse attendant prognostic implications. We therefore suggest that the term athlete's heart, typically used to imply a beneficial adaptive process, is not applicable to the concentric LV hypertrophy that develops among ASF linemen.
Several limitations of this study are noteworthy. First, although our study establishes a strong association between ASF participation and both BP increase and LV remodeling, future work designed to track ASF athletes during and beyond an entire football career is needed to determine the impact of sustained participation on attendant clinical outcomes. Second, our study population was drawn from a single competitive ASF program; thus, differences in athlete ethnicity, training, lifestyle, and dietary intake may somewhat limit the generalizability of our results. Third, although we identified several independent predictors of BP increase during ASF participation, we acknowledge that potentially unidentified confounders may contribute to our observations. Finally, our data do not address the mechanistic underpinnings of why ASF participation leads to increases in BP and concentric LV hypertrophy. Likely contributors include intraseason weight gain, changes in dietary caloric intake and sodium consumption, intrinsic familial predisposition to hypertension, and endothelial dysfunction. Recent data indicate that impaired endothelial function correlates with exaggerated exercise BP response, 28 a marker of increased mean ambulatory BP 29 and future hypertension risk in young adults. 30 It is therefore possible that the repetitive hemodynamic stress inherent in ASF participation results in endothelial dysfunction and corollary changes in resting vascular tone. Careful study of each potential mechanistic factor represents an important area of future work. Additionally, although anabolic steroids have a documented effect on BP, 31 this factor is unlikely to have affected our findings because participants were subjected to random drug testing in accordance with National Collegiate Athletic Association regulations and no athletes enrolled tested positive for banned substances.
Conclusions
Participation in collegiate ASF is associated with statistically significant and clinically relevant increases in BP. ASF athletes who play lineman field positions, gain weight during the season, and have a family history of hypertension appear to be at highest risk for increase in BP and the development of concentric LV hypertrophy. Enhanced surveillance and timely, carefully selected intervention may represent an important opportunity to improve later-life cardiovascular health outcomes in this sizable population.
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CLINICAL PERSPECTIVE
Emerging data indicate that increased blood pressure in early adulthood is associated with cardiovascular disease risk in later life. Identification of populations at risk for early adult hypertension is therefore of critical importance. Prior cross-sectional studies document a high prevalence of hypertension and premature cardiovascular mortality in professional American-style football players. To what degree these findings apply to the large population of younger men who participate in competitive high school or collegiate American-style football in the United States is not known. We conducted a prospective, longitudinal study as part of the Harvard Athlete Initiative to examine blood pressure trends, left ventricular remodeling, and the incidence of hypertension among competitive collegiate American-style football participants. We observed that Americanstyle football participation was associated with significant increases in systolic (116±8 versus 125±13 mm Hg; P<0.001) and diastolic (64±8 mm Hg versus 66±10 mm Hg, P<0.001) blood pressures. At the postseason assessment, the majority of athletes met criteria for Joint National Commission (seventh report) prehypertension (53 of 113, 47%) or stage 1 hypertension (16 of 113, 14%). Several readily available clinical factors, including lineman field position, intraseason weight gain, and a family history of hypertension, identify athletes at greatest risk. Further analyses suggest that the concentric left ventricular hypertrophy in this population is driven by increases in resting blood pressure and not simply the transient isometric stress that occurs during training and competition. Enhanced surveillance and timely, carefully selected intervention may represent an important opportunity to improve later-life cardiovascular health outcomes in this sizable population.
